You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health, behavioural and neurodevelopmental conditions
  5. Anxiety

Generalised anxiety disorder and panic disorder in adults: management

  • Clinical guideline
  • Reference number: CG113
  • Published:  26 January 2011
  • Last updated:  15 June 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Anxiety (partial update): full guideline appendices for consultation

  • Appendix 15 - economic plan

  • Appendix 16a - Experience of Care study characteristics

  • Appendix 16b - low intensity study characteristics

  • Appendix 16c - high intensity study characteristics

  • Appendix 16c - high intensity combination therapies study characteristics table

  • Appendix 16d - Other interventions

  • Appendix 16d - Pharmacology augmentation

  • Appendix 16d - Pharmacology dosage

  • Appendix 16d - Pharmacology interventions

  • Appendix 16d - Pharmacology relapse prevention

  • Appendix 16e - CCBT for panic part one study characteristics

  • Appendix 16e - CCBT for panic part two study characteristics

  • Appendix 16f - HE evidence tables

  • Appendix 16g - Collaborative care study characteristics table

  • Appendix 17a - Low intensity Forest Plots

  • Appendix 17b - High intensity Forest Plots

  • Appendix 17c - Pharmacology forest plots

  • Appendix 17d - CCBT for Panic TA Forest Plots

  • Appendix 18 - Completed HE Checklists

  • Appendix 19a - Low intensity GRADE profiles

  • Appendix 19a - Low intensity psychol HE profiles

  • Appendix 19b - High intensity psychol HE profiles

  • Appendix 19b - High intensity GRADE profile

  • Appendix 19c - GRADE Pharmacology profiles

  • Appendix 19c - pharma HE evidence profiles

  • Appendix 19d - CCBT for Panic TA GRADE evidence profiles

  • Appendix 19d - CCBT for PD HE evidence profiles


This page was last updated: 19 July 2010

Back to top